Mitchell Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,304
Closed -$219K 130
2025
Q3
$219K Buy
+2,304
New +$212K 0.04% 120
2021
Q1
Sell
-10,668
Closed -$1.25M 153
2020
Q4
$1.25M Buy
10,668
+854
+9% +$94K 0.31% 90
2020
Q3
$1.02M Buy
9,814
+200
+2% +$20.1K 0.3% 91
2020
Q2
$882K Buy
9,614
+231
+2% +$22.2K 0.28% 94
2020
Q1
$846K Buy
9,383
+147
+2% +$15.6K 0.33% 87
2019
Q4
$1.05M Sell
9,236
-261
-3% -$28.6K 0.33% 86
2019
Q3
$1.03M Buy
9,497
+464
+5% +$48.4K 0.35% 80
2019
Q2
$880K Buy
9,033
+382
+4% +$34.9K 0.3% 85
2019
Q1
$788K Sell
8,651
-2,861
-25% -$256K 0.28% 83
2018
Q4
$1.05M Buy
11,512
+1,037
+10% +$96.9K 0.44% 54
2018
Q3
$1.03M Buy
10,475
+959
+10% +$88.7K 0.33% 65
2018
Q2
$815K Buy
9,516
+4,978
+110% +$416K 0.29% 60
2018
Q1
$364K Buy
4,538
+1,931
+74% +$159K 0.13% 92
2017
Q4
$211K Buy
+2,607
New +$209K 0.07% 91

Other funds holding MDT

Mitchell Capital Management's MDT Position: Q4 2025 in Review

Mitchell Capital Management sold out of Medtronic (MDT) in Q4 2025, closing a stake of 2,304 shares — an estimated $219K sold.

Mitchell Capital Management first reported a position in MDT in Q4 2017 and held it in 14 quarters. The position peaked at $1.25M in Q4 2020. 2,312 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Mitchell Capital Management reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • Mitchell Capital Management sold 2,304 Medtronic shares in Q4 2025, an estimated $219K.
  • Mitchell Capital Management first reported a position in Medtronic in Q4 2017 and held it in 14 quarters.
  • Mitchell Capital Management's Medtronic position peaked at $1.25M in Q4 2020.
  • 2,312 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Mitchell Capital Management's 13F filing for Q4 2025, filed 10 Feb 2026.